Matthew Devall

Postdoctoral researcher
University Medical Centre of Utrecht

Since leaving the complex disease epigentics group after graduating his PhD, Matthew moved to the University Medical Centre of Utrecht where he works as a postdoctoral researcher. Through the analysis and integration of transcriptomic and methylomic data, Matthew has since worked on whether such data layers can be used to predict treatment response to TNF-alpha, the most commonly used drug in the treatment of Rheumatoid Arthritis.